Impaktované publikace
Battipaglia, G.; Labopin, M.; Kroger, N.; Vitek, A.; et al.
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation
[rok vydání 2019, impact factor 17.794 ]
Tanase, A.; Schmitz, N.; Stein, H.; Boumendil, A.; Finel, H.; Castagna, L.; Blaise, D.; Milpied, N.; Sucak, G.; Sureda, A.; Thomson, K.; Vandenberghe, E.; Vitek, A.; Dreger, P.
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
[rok vydání 2015, impact factor 12.104 ]
Lorentino, F.; Labopin, M.; Ciceri, F.; Vago, L.; Fleischhauer, K.; Afanasyev, B.; Kröger, N.; Cornelissen, J.J.; Lovira, M.; Meijer, E.; Vitek, A.; et al.
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia
[rok vydání 2020, impact factor 11.528 ]
Hernández-Boluda, J.C.; Pereira, A.; Kröger, N.; Beelen, D.; Robin, M.; Bornhäuser, M.; Angelucci, E.; Vítek, A.; et al.
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
[rok vydání 2020, impact factor 11.528 ]
Gilleece, M.H.; Shimoni, A.; Labopin, M.; Robinson, S.; Beelen, D.; Socié, G.; Unal, A.; Ganser, A.; Vitek, A.; Sengeloev, H.; Yakoub-Agha, I.; Tholouli, E.; Polge, E.; Mohty, M.; Nagler, A.
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT
[rok vydání 2021, impact factor 11.037 ]
Crawley, CH.; Szydlo, R.; Lalancette, M.; Bacigalupo, A.; Lange, A.; Brune, M.; Juliusson, G.; Nagler, A.; Gratwohl, A.; Passweg, J.; Komarnicki, M.; Vítek, A.; Mayer, J.; Zander, A.; Sierra, J.; Rambaldi, A.; Ringden, O.; Niederwieser, D.; Apperley, J.F.:
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia : an analysis of prognostic factors from the Chronic leukemia working party of the EBMT.
[rok vydání 2006, impact factor 10.131]
Averbuch, D.; Tridello, G.; Hoek, J.; Mikulska, M.; Akan, H.; Yaňez San Segundo, L.; Pabst, T.; Özçelik, T.; Klyasova, G.; Donnini, I.; Wu, D.; Gülbas, Z.; Zuckerman, T.; Botelho De Sousa, A.; Beguin, Y.; Xhaard, A.; Bachy, E.; Ljungman, P.; De La Camara, R.; Rascon, J.; Ruiz Camps, I.; Vitek, A.; et al.
Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group
[rok vydání 2017, impact factor 9.117 ]
Michallet, M.; Sobh, M.; Milligan, D.; Morisset, S.; Niederwieser, D.; Koza, V.; Ruutu, T.; Russell, N.H.; Verdonck, L.; Dhedin, N.; Vitek, A.; Boogaerts, M.; Vindelov, L.; Finke, J.; Dubois, V.; van Biezen, A.; Brand, R.; de Witte, T.; Dreger, P.
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL : a retrospective study from the EBMT registry
[rok vydání 2010, impact factor 8.966]
Schetelig, J.; de Wreede, L.C.; van Gelder, M.; Koster, L.; Finke, J.; Niederwieser, D.; Beelen, D.; Mufti, G.J.; Platzbecker, U.; Ganser, A.; Heidenreich, S.; Maertens, J.; Socié, G.; Brecht, A.; Stelljes, M.; Kobbe, G.; Volin, L.; Nagler, A.; Vitek, A.; et al.
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
[rok vydání 2019, impact factor 8.665 ]
Brissot, E.; Labopin, M.; Stelljes, M.; Ehninger, G.; Schwerdtfeger, R.; Finke, J.; Kolb, H.J.; Ganser, A.; Schäfer-Eckart, K.; Zander, A.R.; Bunjes, D.; Mielke, S.; Bethge, W.A.; Milpied, N.; Kalhs, P.; Blau, I.W.; Kröger, N.; Vitek, A.; et al.
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
[rok vydání 2017, impact factor 7.333 ]
Robin, M.; De Wreede, L.C.; Wolschke, C.; Schetelig, J.; Eikema, D.-J.; Van Lint, M.T.; Knelange, N.S.; Beelen, D.; Brecht, A.; Niederwieser, D.; Vitek, A.; et al.
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
[rok vydání 2019, impact factor 7.116 ]
Canaani, J.; Labopin, M.; Huang, X.-J.; Arcese, W.; Ciceri, F.; Blaise, D.; Irrera, G.; Corral, L.L.; Bruno, B.; Santarone, S.; Van Lint, M.T.; Vitek, A.; et al.
T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
[rok vydání 2018, impact factor 6.137 ]
Bazarbachi, A.; Labopin, M.; Angelucci, E.; Gulbas, Z.; Ozdogu, H.; Arat, M.; de Rosa, L.; Pastano, R.; Pioltelli, P.; Montserrat, R.; Martino, M.; Ciceri, F.; Koç, Y.; Socie, G.; Blaise, D.; Herrera, C.; Chalandon, Y.; Bernasconi, P.; Marotta, G.; Castagna, L.; McDonald, A.; Visani, G.; Carluccio, P.; Vitek, A.; et al.
Haploidentical transplantation with post-transplantation cyclophosphamide for T cell acute lymphoblastic leukemia: a report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
[rok vydání 2020, impact factor 5.742 ]
Ruggeri, A.; Labopin, M.; Battipaglia, G.; Chiusolo, P.; Tischer, J.; Diez-Martin, J.L.; Bruno, B.; Castagna, L.; Moiseev, I.S.; Vitek, A.; et al.
Timing of post-transplantation cyclophosphamide administration in haploidentical transplantation: a comparative study on behalf of the acute leukemia working party of the European Society for Blood and Marrow Transplantation
[rok vydání 2020, impact factor 5.742 ]
Cordonnier, C.; Martino, R.; Trabasso, P.; Held, T.K.; Akan, H.; Ward, M.S.; Fabian, K.; Ullmann, A.J.; Wulffraat, N.; Ljungman, P.; Alessandrino, E.P.; Pretnar, J.; Gmür, J.; Varela, R.; Vítek, A.; Sica, S.; Rovira, M.
Mycobacterial infection : a difficult and late diagnosis in stem cell transplant recipients
[rok vydání 2006, impact factor 5.594]
Swoboda, R.; Labopin, M.; Giebel, S.; Angelucci, E.; Arat, M.; Aljurf, M.; Sica, S.; Pavlu, J.; Socié, G.; Bernasconi, P.; Rigacci, K.; Tischer, J.; Risitano, A.; Rovira, M.; Saccardi, R.; Pioltelli, P.; Van Gorkom, G.; Vitek, A.; et al.
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation: a study by the Acute Leukemia Working Party of the EBMT
[rok vydání 2022, impact factor 5.483 ]
Battipaglia, G.; Galimard, J.E.; Labopin, M.; Raiola, A.M.; Blaise, D.; Ruggeri, A.; Koc, Y.; Gülbas, Z.; Vitek, A.; et al.
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT
[rok vydání 2022, impact factor 5.483 ]
McLornan, D.P.; Szydlo, R.; Robin, M.; van Biezen, A.; Koster, L.; Blok, H.J.P.; Van Lint, M.T.; Finke, J.; Vitek, A.; et al.
Outcome of patients with myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
[rok vydání 2018, impact factor 5.206 ]
Schetelig, J.; de Wreede, L.C.; Andersen, N.S.; Moreno, C.; van Gelder, M.; Vitek, A.; et al.
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: A retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)
[rok vydání 2017, impact factor 5.128 ]
Olavarria, E.; Ottmann, O.G.; Deininger, M.; Clark, R.E.; Bandini, G.; Byrne, J.; Lipton, J.; Vitek, A.; Michallet, M.; Siegert, W.; Ullmann, A.; Wassmann, B.; Niederwieser, D.; Fischer, T.
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
[rok vydání 2011, impact factor 5.116 ]